Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)
China · Delayed Price · Currency is CNY 12.34
-0.27 (-2.14%)
Nov 13, 2026, 3:00 PM CST
SHA:600129 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 9,588 | 10,500 | 12,386 | 15,623 | 14,127 | 12,149 |
Revenue Growth | -4.50% | -15.23% | -20.72% | 10.58% | 16.28% | 8.40% |
Gross Profit Gross Profit Growth | 2,811 | 3,045 | 4,827 | 7,493 | 6,356 | 5,098 |
Operating Income Operating Income Growth | 120.86 | 283.32 | 438.9 | 1,103 | 656.01 | -226.97 |
Net Income Net Income Growth | -19.62 | 120.57 | 26.65 | 822.12 | 354.38 | -523.17 |
Earnings Per Share EPS Growth | -0.04 | 0.22 | 0.05 | 1.48 | 0.64 | -0.94 |
EPS Growth | - | 340.00% | -96.62% | 131.25% | - | - |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical commercial Pharmaceutical commercial Growth | 6,289 |
Chinese Herbal Medicine Resources Chinese Herbal Medicine Resources Growth | 1,199 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -2,622 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 5,472 |
Big Health Big Health Growth | 154.87 |
Service Industry and Others Service Industry and Others Growth | 7.68 |
Total Total Growth | 10,500 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 518.12 | 1,170 | 953.11 | 2,101 | 2,630 | 1,863 |
Total Debt Total Debt Growth | 5,433 | 5,432 | 5,098 | 4,225 | 4,642 | 4,812 |
Net Cash (Debt) Net Cash Growth | -4,915 | -4,262 | -4,145 | -2,124 | -2,013 | -2,949 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.47 | -7.78 | -7.78 | -3.82 | -3.64 | -5.30 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 185.2 | 583.88 | -631.46 | 671.54 | 1,781 | 558.81 |
Capital Expenditures CapEx Growth | -400.12 | -523.16 | -831.73 | -835.59 | -531.89 | -500.11 |
Free Cash Flow Free Cash Flow Growth | -214.92 | 60.73 | -1,463 | -164.05 | 1,249 | 58.7 |
Free Cash Flow Growth | - | - | - | - | 2027.38% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.32% | 29.00% | 38.97% | 47.97% | 44.99% | 41.96% |
Operating Margin | 1.26% | 2.70% | 3.54% | 7.06% | 4.64% | -1.87% |
Pretax Margin | 0.67% | 2.11% | 2.61% | 6.57% | 3.19% | -4.07% |
Profit Margin | -0.21% | 1.15% | 0.21% | 5.26% | 2.51% | -4.31% |
FCF Margin | -2.24% | 0.58% | -11.81% | -1.05% | 8.84% | 0.48% |
Fiscal Year | FY 2023 |
|---|---|
| Period Ending | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.300 |
Dividend Per Share Growth | - |
Dividend Yield | 0.65% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 82.55 | 516.51 | 31.47 | 47.24 | - |
Forward PE | 24.68 | 12.29 | 12.69 | 23.01 | 33.68 | 11.61 |
P/FCF Ratio | - | 163.90 | - | - | 13.41 | 213.08 |
PS Ratio | 0.71 | 0.95 | 1.11 | 1.66 | 1.19 | 1.03 |